Company Overview
Snapshot
Founded in February 2021, RNAway operates with 1–10 employees and has secured funding across one round from Copia Agro & Food. The company is developing a patented platform technology for RNA molecule delivery into plants, leveraging nanotechnology, drug delivery, and gene therapy expertise.
Business overview
RNAway is an Agriculture & Food Technologies company that develops and markets a patented platform technology designed to deliver RNA molecules into plants via spray or irrigation. This technology is based on groundbreaking research in nanotechnology, drug delivery, and gene therapy, offering a novel approach for various agricultural applications. The company serves crop protection companies, providing them with proof-of-concepts to further develop into commercialized products within the Ag Tech sector, specifically focusing on Genetics & Input.
Log in to access full profile ›Company Intelligence Q&A
- What is RNAway's core technology?
- RNAway develops a patented platform technology for delivering RNA molecules into plants via spray or irrigation, utilizing nanotechnology, drug delivery, and gene therapy expertise for agricultural applications.
- When was RNAway founded?
- RNAway was founded in February 2021.
- What is RNAway's primary sector?
- RNAway operates primarily within the Agriculture & Food Technologies sector.